AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
PRESS RELEASE AB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES…
Frontline Performance Group Launches CheckMax with AI Insights to Maximize F&B Profits
Bigger Profits, Better Service: CheckMax Tackles Top Restaurant Challenges ORLANDO, Fla., Dec. 9,…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
Zero Trust Security Reduces Cyber Insurance Claims, Preventing up to $465 Billion Annually in Global Economic Loss from Cyber Attacks
Nearly a third of the cyber events encompassed by the study potentially…
Colt, Honeywell and Nokia join forces to trial space-based quantum-safe cryptography
Press ReleaseColt, Honeywell and Nokia join forces to trial space-based quantum-safe cryptography…